Real-World Study of Patients With Type 1 Diabetes Treated With Teplizumab as Part of Managed Access Programs (MAPs)
Clinical trial NCT07457580 · RECRUITING
Trial details
- NCT number
- NCT07457580
- Sponsor
- Sanofi
- Status
- RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2026-03-16
- Primary completion
- 2026-11-30
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.